Clinical Trial in India & Europe for Mitral Regurgitation Device

Published date : 16 January 2013
Article date : 16 January 2013


Redorbit reports on a press release from Phoenix Cardiac Devices which announces the start of a clinical trial in India and Europe that will test their BACE device for the treatment of mitral regurgitation without open heart surgery. Apparently, the manufacturer has enrolled its first patient in a clinical trial aimed at achieving CE Mark approval in Europe.

They say the the trial will assess the safety and efficacy of the BACE device which is an adjustable tension band that encircles the heart and supports the mitral valve leaflets so they close properly to prevent the back flow of blood into the heart.

Previous studies of BACE, including a proof of concept study in 12 patients and a feasibility study in 14 patients, demonstrated a significant reduction in mitral regurgitation and no device-related serious adverse events following implantation. Results of the proof of concept study were published in the Australian journal, Heart, Lung and Circulation in December, 2009. The current study will enroll 60 patients in India and Europe who have moderate to severe functional mitral regurgitation.

The BACE can be remotely adjusted from an external port and its efficacy can be assessed through real-time echocardiography whih allow immediate adjustments in tension and pressure.

Source:, 14 January 2013.

Read the full article here.

Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.